Katie Szyman's guest appearances

Katie Szyman

Medtech Talk

DeviceTalks

Scott Whitaker

Fred Lampropoulos

Bruce Shook

Scott Huennekens

Duke Rohlen

Jon Norris

Stacy Enxing Seng

Joe Almeida

Kevin Lobo

Todd Pope

Merit Medical

David Muller

Joe Mullings

Art Collins

Joe Kiani

OwlTail

Naomi Murray

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design &amp; Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company.In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design &amp; Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical. Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company. In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech? Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar

Katie Szyman is an accomplished global operating executive in the medical device industry with a passion for building high performing teams and helping innovative healthcare companies grow so patients can gain access to better therapies and outcomes. Here she shares how Edwards, critical care, and the medtech industry is adapting to COVID19, her leadership role models, and tips for expanding diversity on leadership teams and executive boards.

Katie Szyman is an accomplished global operating executive in the medical device industry with a passion for building high performing teams and helping innovative healthcare companies grow so patients can gain access to better therapies and outcomes. Here she shares how Edwards, critical care, and the medtech industry is adapting to COVID19, her leadership role models, and tips for expanding diversity on leadership teams and executive boards.

Episode 150: Edwards' Katie Szyman on Medtech's Accelerating Changes, Leadership Development and Having Fun